Text Size

Ocular tolerability and efficacy of a cationic emulsion in patients with mild to moderate dry eye disease – A randomised comparative study

Amrane M., Creuzot-Garcher C., Robert P.-Y., Ismail D., Garrigue J.-S., Pisella P.-J., Baudouin C.


  • 2014
  • Journal Francais d'Ophtalmologie
View publication
  • Therapeutic Area

    Front of the eye (FOTE)

  • Categories

    Clinical development

  • Affiliations

    Santen SAS, 1, rue Pierre-Fontaine, Evry cedex, 91058, France; Service D'ophtalmologie, CHU de Dijon, 3, rue du Faubourg-Raines, Dijon, 21000, France; Service D'ophtalmologie, CHU Dupuytren, 2, avenue Martin-Luther-King, Limoges, 87000, France; Service D'ophtalmologie, CHU Bretonneau, 2, boulevard Tonnellé, Tours, 37000, France; Service D'ophtalmologie, Centre National D'ophtalmologie des Quinze-Vingts, Institut de la Vision, 28, rue de Charenton, Paris, 75012, France; Hôpital Ambroise-Paré, AP-HP, 9, avenue Charles-de-Gaulle, Boulogne-Billancourt, 92100, France; Université de Versailles Saint-Quentin-en-Yvelines, 55, avenue de Paris, Versailles, 78000, France

Related Publications

Efficacy and Tolerance of Nova22007 Versus Vehicle in Patients With Vernal Keratoconjunctivitis (NOVATIVE): A Phase II/III, Multicenter, Double-masked, Randomized Study of 0.05% Cyclosporine A and 0.1% Ophthalmic Cationic Emulsion Versus Vehicle in Patients With Vernal Keratoconjunctivitis

Leonardi A, Pisella PJ, Benítez-Del-Castillo JM, Amrane M, Ismail D, Doan S, Bremond-Gignac D.


Correlation between gene expression and clinical scores in vernal keratoconjunctivitis

Leonardi A, Cavarzeran F, Rosani U, Righetti G, Garrigue JS, Brun P.


Topical cyclosporine A cationic ophthalmic emulsion in paediatric vernal keratoconjunctivitis: pooled analysis of randomised NOVATIVE and VEKTIS trials

Leonardi A, Doan S, Aragona P,  Amrane M, Ismail D, Montero J, Németh J, Bremond-Gignac D


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022